COLLEGE PARK, Md. (WJZ) A rising senior at the University of Maryland, College Park is being recognized for her volunteer work through the COVID-19 pandemic.

The bioengineering major used social media to organize cloth drives to collect T-shirts for to make face coverings.

CORONAVIRUS COVERAGE:

Vaani Shah makes and delivers the masks to her local health department, which are then given out to frontline workers, COVID-19 patients and their visitors.

Since starting the project, hundreds of masks have been made and delivered.

Shah also volunteers at the Frederick Community Action Agency to help pack bags of food for families in need.

For the latest information on coronavirus go to theMaryland Health Departments websiteor call 211. You can find all of WJZs coverage oncoronavirus in Maryland here.

View post:
University Of Maryland Student Collects T-Shirts To Make Face Coverings For Those In Need During COVID-19 Pandemic - CBS Baltimore

Buy Photo

Congratulations to the 2020 Rockland Scholar-Athletes From top, L to R -Danny Linehan, Tappan Zee boys basketball, Skenlanda Marseille, Ramapo track and field, Daly Dedyo, Albertus Magnus field hockey, Yvianick Saint-Vil, Nyack track and field, Billy Gunn, Pearl River boys soccer, Dariel Guzman, North Rockland football, Luke Rogers, Clarkstown South wrestling, Haleigh Morales, North Rockland track and field, CJ Olsen, Suffern hockey, Elijah Gray, Nyack football, Kayleigh Beirne, Tappan Zee girls basketball, Patrick Reda, Suffern wrestling, Grace Krebs, Suffern field hockey, Kiara Ekeigwe, Ramapo track, Katelyn Tuohy, North Rockland cross country, Dylan Shalvey, Tappan Zee boys soccer, Justin Haughton, Nanuet boys basketball, Sydney Miller, Clarkstown North girls tennis, Daniel Kelkay, Spring Valley boys track and field, Jolie Santiago, Clarkstown South volleyball, Julian Brooks, Nyack baseball, Jason Olszewski, Tappan Zee lacrosse, Rebecca Heuler, Tappan Zee volleyball, Corinne Miedreich, Pearl River girls basketball, Camryn McGee, Pearl River softball, Mary Hennelly, Suffern track, Matt Konicoff, North Rockland boys basketball, Isabella Villarente, East Ramapo volleyball, Abbey Knobel, Nanuet girls soccer, Brady Timmerberg, Clarkstown South baseball(Photo: Journal News photo staff)

See the original post here:
2019-20 Rockland Scholar-Athletes honored in virtual celebration by Journal News/lohud - Lohud

The College of Engineering and the School of Medicine at theUniversity of Washington invite applications and nominations forChair of the Department of Bioengineering. This full-time andtenured position with the appointment at the rank of Professorwill lead a department with a long history of dedication toexcellence, tremendous growth and accomplishment in research andscholarship, state-of-the-art facilities, and strong connections toindustries. This is a 12-month service period per year position(July June) with an anticipated start date in Summer 2021.All University of Washington faculty engage in teaching, researchand service.

The Chair will build on the departments commitment to inclusiveand excellent undergraduate and graduate education and research.The chair will lead the department to provide leadership andservice in research, education, and diversity to the University,the state of Washington, the nation, and the community.TheChair will be expected to represent the department with alumni,donors, industry and the community,and lead advancementactivities.

The University of Washington is ranked No. 3 among U.S. publicuniversities and 14th in the world on the 2019 Academic Ranking ofWorld Universities with a graduate Bioengineering programthat consistently ranks in top 10 (the US News ranking). UWBioengineering has a tradition of interdisciplinary collaborationsand strong partnerships between the College of Engineering and theSchool of Medicine as well as with industry, national labs, andother academic institutions. Major areas of research include:

The departments faculty have played a central role in majorcollaborative centers at the University such as the newly formedUWEB-21, National ESCA and Surface Analysis Center for BiomedicalProblems (NESAC-BIO),Ultrasound-based Washington Molecular Imagingand Therapy Center (uWAMIT), The Institute of Stem Cell &Regenerative Medicine (ISCRM), the Center for CardiovascularBiology (CCVB), Molecular Engineering and Sciences Institute(MolES), the Institute for Protein Design (IPD) and the Center forNeurotechnology (CNT) among many other inter-departmental,multi-disciplinary and multi-institutional Centers. The new chairwill also have a unique opportunity to lead the department in newresearch directions that engage in the UWs new Population HealthInitiative, which seeks to address all causes of healthinequities. The department currently consists of 49 coretenure/tenure-track and research faculty, 85 administrative andresearch staff, 211 undergraduates, 66 masters and 116 PhDstudents. For more information on the department, pleasevisithttps://bioe.uw.edu/

Our objective is to create a community that encouragesparticipation and connection and values each persons uniquecontributions, regardless of socioeconomic status, race, ethnicity,language, nationality, sex, sexual orientation, gender identity andexpression, spiritual practice, geography, mental and physicalstatus and age.

The search is open to candidates with a Ph.D. degree, MD orforeign equivalent and national leadership experience. Anoutstanding record of scholarship, undergraduate and graduateeducation, along with demonstrated collaborative leadership andmanagement skills and a demonstrated commitment to advancingdiversity, equity and inclusion are required.

In order to be eligible for University sponsorship for an H-1Bvisa, graduates of foreign (non-U.S.) medical schools must showsuccessful completion of all three steps of the U.S. MedicalLicensing Exam (USMLE), or foreign equivalent as determined by theSecretary of Health and Human Services.

Applications should include:

Please submit the nominations or applications by July 31, 2020via Interfolio.

For any administrative issues related to this search, pleasecontact the search committee at chemeatc@uw.edu.

Review of applications will begin on August 1, 2020 and continueuntil the position is filled.

University of Washington is an affirmative action and equalopportunity employer. All qualified applicants will receiveconsideration for employment without regard to race, color, creed,religion, national origin, sex, sexual orientation, marital status,pregnancy, genetic information, gender identity or expression, age,disability, or protected veteran status.

Commitment to Diversity

The University of Washington is committed to building diversityamong its faculty, librarian, staff, and student communities, andarticulates that commitment in the UW Diversity Blueprint (http://www.washington.edu/diversity/diversity-blueprint/).Additionally, the Universitys Faculty Code recognizes facultyefforts in research, teaching and/or service that address diversityand equal opportunity as important contributions to a facultymembers academic profile and responsibilities (https://www.washington.edu/admin/rules/policies/FCG/FCCH24.html#2432).

Follow this link:
Chair - Department of Bioengineering job with University of Washington | 270154 - The Chronicle of Higher Education

Simulation Software Market is analyzed with industry experts in mind to maximize return on investment by providing clear information needed for informed business decisions. This research will help both established and new entrants to identify and analyze market needs, market size and competition. It explains the supply and demand situation, the competitive scenario, and the challenges for market growth, market opportunities and the threats faced by key players.

Sample Copy of This Report:https://www.quincemarketinsights.com/request-sample-62946

A 360 degree outline of the competitive scenario of the Global Simulation SoftwareMarket is presented by QuinceMarketInsights. It has a massive data allied to the recent product and technological developments in the markets.

It has a wide-ranging analysis of the impact of these advancements on the markets future growth, wide-ranging analysis of these extensions on the markets future growth. The research report studies the market in a detailed manner by explaining the key facets of the market that are foreseeable to have a countable stimulus on its developing extrapolations over the forecast period.

Key Players: Altair Engineering, Inc.; ANSYS, Inc.; Autodesk, Inc.; Bentley Systems; Dassault Systmes; Hexagon (MSC Software Corporation); The MathWorks, Inc.; PTC, Inc.; Siemens PLM Software; AnyLogic Company

Reasons for buying this report:

By Component (Software and Services)

By Deployment Mode (On-premise and Cloud)

By Industry Vertical (Architecture, Engineering, Construction (AEC), Aerospace & Defense, Automotive, Electrical & Electronics, Healthcare, Others)

Get Discount on This Report: https://www.quincemarketinsights.com/request-discount-62946

A detailed outline of the Global Simulation SoftwareMarket includes a comprehensive analysis of different verticals of businesses. North America, Europe, Asia Pacific, Middle East & Africa, and South America have been considered for the studies on the basis of several terminologies.

This is anticipated to drive the Global Simulation SoftwareMarket over the forecast period. This research report covers the market landscape and its progress prospects in the near future. After studying key companies, the report focuses on the new entrants contributing to the growth of the market. Most companies in the Global Simulation SoftwareMarket are currently adopting new technological trends in the market.

Finally, the researchers throw light on different ways to discover the strengths, weaknesses, opportunities, and threats affecting the growth of the Global Simulation SoftwareMarket. The feasibility of the new report is also measured in this research report.

If You Have Any Query, Ask Our Experts:https://www.quincemarketinsights.com/enquiry-before-buying-62946

Table of Contents:

ABOUT US:

QMI has the most comprehensive collection of market research products and services available on the web. We deliver reports from virtually all major publications and refresh our list regularly to provide you with immediate online access to the worlds most extensive and up-to-date archive of professional insights into global markets, companies, goods, and patterns.

Contact:

Quince Market Insights

Ajay D. (Knowledge Partner)

Office No- A109

Pune, Maharashtra 411028

Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 121 364 6144

Email:sales@quincemarketinsights.com

Web:https://www.quincemarketinsights.com

Go here to see the original:
Impact of Covid-19 on Simulation Software Market Outlook, Revenue, Trends and Forecasts Research Report... - Azizsalon News

Bacillus Licheniformis Market Latest Research Report 2020:

The Bacillus Licheniformis report provides an independent information about the Bacillus Licheniformis industry supported by extensive research on factors such as industry segments size & trends, inhibitors, dynamics, drivers, opportunities & challenges, environment & policy, cost overview, porters five force analysis, and key companies

Download Premium Sample Copy Of This Report: Download FREE Sample PDF!

In this report, our team offers a thorough investigation of Bacillus Licheniformis Market, SWOT examination of the most prominent players right now. Alongside an industrial chain, market measurements regarding revenue, sales, value, capacity, regional market examination, section insightful information, and market forecast are offered in the full investigation, and so forth.

Scope of Bacillus Licheniformis Market:Products in the Bacillus Licheniformis classification furnish clients with assets to get ready for tests, tests, and evaluations.

Major Company Profiles Covered in This Report

Wuhan Nature?s Favour Bioengineering, Henan Yi Kang Bioengineering, Beihai Qunlin Shengwu Gongcheng, Xianpuairui Technology, Cangzhou Industrial Biological Technology, Zhengzhou Jinbaihe Biology Engineering, Shandong Gaolong Biology Technology, Cangzhou Wangfa Biology Technology, Cangzhou Huayu Biology Technology, Cangzhou Zhongxin Biology Technology, Shandong Tianxing Bio-Fechnology,

1. To provide a detailed investigation of the market structure alongside conjecture of the different sections and sub-portions of the worldwide Bacillus Licheniformis Market.

Bacillus Licheniformis Market Report Covers the Following Segments:

Market segment by Type, the product can be split into

Powder, Solution, Others,

Market segment by Application, split into

Medical, Agriculture, Others,

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

North America

Europe

Asia-Pacific

South America

Center East and Africa

United States, Canada and Mexico

Germany, France, UK, Russia and Italy

China, Japan, Korea, India and Southeast Asia

Brazil, Argentina, Colombia

Saudi Arabia, UAE, Egypt, Nigeria and South Africa

Table of Content:

Market Overview:The report begins with this section where product overview and highlights of product and application segments of the global Bacillus Licheniformis Market are provided. Highlights of the segmentation study include price, revenue, sales, sales growth rate, and market share by product.

Competition by Company:Here, the competition in the Worldwide Bacillus Licheniformis Market is analyzed, By price, revenue, sales, and market share by company, market rate, competitive situations Landscape, and latest trends, merger, expansion, acquisition, and market shares of top companies.

Company Profiles and Sales Data:As the name suggests, this section gives the sales data of key players of the global Bacillus Licheniformis Market as well as some useful information on their business. It talks about the gross margin, price, revenue, products, and their specifications, type, applications, competitors, manufacturing base, and the main business of key players operating in the global Bacillus Licheniformis Market.

Market Status and Outlook by Region:In this section, the report discusses about gross margin, sales, revenue, production, market share, CAGR, and market size by region. Here, the global Bacillus Licheniformis Market is deeply analyzed on the basis of regions and countries such as North America, Europe, China, India, Japan, and the MEA.

Application or End User:This section of the research study shows how different end-user/application segments contribute to the global Bacillus Licheniformis Market.

Market Forecast:Here, the report offers a complete forecast of the global Bacillus Licheniformis Market by product, application, and region. It also offers global sales and revenue forecast for all years of the forecast period.

Research Findings and Conclusion:This is one of the last sections of the report where the findings of the analysts and the conclusion of the research study are provided.

For detailed informationhttps://brandessenceresearch.biz/Lifesciences-and-Healthcare/Global-and-China-Bacillus-Licheniformis-Market-Research-by-Company-TypeApplication-2013-2025/Summary

About Us:

We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students.

Top Trending Reports:

https://www.marketwatch.com/press-release/microfluidic-devices-market-share-trends-opportunity-and-forecast-2020-2025-covid-19-impact-analysis-bmrc-2020-05-28?tesla=y

https://www.marketwatch.com/press-release/europe-underwater-camera-market-size-share-application-analysis-regional-outlook-growth-trends-key-players-and-competitive-strategies-forecast-to-2025-2020-05-28?tesla=y

https://www.marketwatch.com/press-release/us-medical-device-packaging-market-2020-industry-research-share-trend-industry-size-opportunity-and-corona-outbreak-analysis-2025-2020-05-28?tesla=y

See the original post:
BacillLicheniformis Market is expected to boom in 2020 3w Market News Reports - 3rd Watch News

The Ultrafilter market research encompasses an exhaustive analysis of the market outlook, framework, and socio-economic impacts. The report covers the accurate investigation of the market size, share, product footprint, revenue, and progress rate. Driven by primary and secondary researches, the Ultrafilter market study offers reliable and authentic projections regarding the technical jargon.All the players running in the global Ultrafilter market are elaborated thoroughly in the Ultrafilter market report on the basis of proprietary technologies, distribution channels, industrial penetration, manufacturing processes, and revenue. In addition, the report examines R&D developments, legal policies, and strategies defining the competitiveness of the Ultrafilter market players.The report on the Ultrafilter market provides a birds eye view of the current proceeding within the Ultrafilter market. Further, the report also takes into account the impact of the novel COVID-19 pandemic on the Ultrafilter market and offers a clear assessment of the projected market fluctuations during the forecast period.

Get Free Sample PDF (including COVID19 Impact Analysis, full TOC, Tables and Figures) of Market Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2632556&source=atm

Market Segment AnalysisThe research report includes specific segments by Type and by Application. Each type provides information about the production during the forecast period of 2015 to 2026. Application segment also provides consumption during the forecast period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.Segment by TypeTube TypeRoll Type

Segment by ApplicationMedicalFood IndustryBioengineeringOthers

Global Ultrafilter Market: Regional AnalysisThe report offers in-depth assessment of the growth and other aspects of the Ultrafilter market in important regions, including the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.Global Ultrafilter Market: Competitive LandscapeThis section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and production by manufacturers during the forecast period of 2015 to 2019.The major players in the market include Baxter International, Medivators, Nipro, Medica, Kawasumi, Baxter, Sorin, Farmasol, Maquet, Silver Med, etc.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected] https://www.researchmoz.com/enquiry.php?type=E&repid=2632556&source=atm

Objectives of the Ultrafilter Market Study:To define, describe, and analyze the global Ultrafilter market based on oil type, product type, ship type, and regionTo forecast and analyze the Ultrafilter market size (in terms of value and volume) and submarkets in 5 regions, namely, APAC, Europe, North America, Central & South America, and the Middle East & AfricaTo forecast and analyze the Ultrafilter market at country-level for each regionTo strategically analyze each submarket with respect to individual growth trends and their contribution to the global Ultrafilter marketTo analyze opportunities in the market for stakeholders by identifying high growth segments of the global Ultrafilter marketTo identify trends and factors driving or inhibiting the growth of the market and submarketsTo analyze competitive developments, such as expansions and new product launches, in the global Ultrafilter marketTo strategically profile key market players and comprehensively analyze their growth strategiesThe Ultrafilter market research focuses on the market structure and various factors (positive and negative) affecting the growth of the market. The study encloses a precise evaluation of the Ultrafilter market, including growth rate, current scenario, and volume inflation prospects, on the basis of DROT and Porters Five Forces analyses. In addition, the Ultrafilter market study provides reliable and authentic projections regarding the technical jargon.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2632556&licType=S&source=atm

After reading the Ultrafilter market report, readers can:Identify the factors affecting the Ultrafilter market growth drivers, restraints, opportunities and trends.Examine the Y-o-Y growth of the global Ultrafilter market.Analyze trends impacting the demand prospect for the Ultrafilter in various regions.Recognize different tactics leveraged by players of the global Ultrafilter market.Identify the Ultrafilter market impact on various industries.

Read more:
Addressing the potential impact of coronavirus disease (COVID-19) on Ultrafilter Market 2019 High Demands, Trends Analysis, Size, Share, Growth...

The research study presented here is an intelligent take on the global Thymosin Market that explains important aspects such as competition, segmentation, and regional growth in great detail. Accuracy and preciseness are two of the key features of the report that reflect its authenticity. The authors of the report have focused on SWOT analysis, Porters Five Forces analysis, and PESTLE analysis of the global Thymosin market. In addition, they have concentrated on qualitative and quantitative analyses to help with a deep understanding of the global Thymosin market. Furthermore, the report provides powerful suggestions and recommendations to help players create strong growth strategies and ensure impressive sales in the global Thymosin market.

Some of the influential Key Players operated in the report are: , Roche, Leadiant Biosciences, SciClone, Merck, Sclavo, AdiStem, Lee Pharma, Abbiotec, Shanghai Soho-Yiming Pharmaceuticals, Hybio Pharmaceutical, Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical, Jiangsu Haosen Pharmaceutical Group, Beijing Northland Biotechnology, Changchun Jinsai Pharmaceutical, Harbin Pharmaceutical Group Bioengineering, Chengdu Shengnuo Biopharmaceutical, Chengdu Diao Jiuhong Pharmaceutical Factory, Hainan Zhonghe Pharmaceutical, Hainan Shuangcheng Pharmaceutical, Wuxi Kaifu Pharmaceutical, Hunan Yige Pharmaceutical, Xi an Disai bio-pharmaceutical, Jilin Connell Pharmaceutical, Harbin High-Tech Group Baitianer Pharmaceutical, Heilongjiang Xiren Pharmaceutical Group, Heilongjiang Dilong Pharmaceutical, Shanghai Baolong Pharmaceutical Market Segment by Type, Thymosin Alpha-1, Thymosin Alpha-2, Thymosin Beta-4 Market Segment by Application, Emphysema, Motor Neurone Disease, Malnutrition, Diabetes, Infection, Cancer, Hair Loss, Wound Healing, Other Research Methodology To compile the detailed study of the global Thymosin market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Thymosin market. QY Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Thymosin market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.

To compile the detailed study of the global Thymosin market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Thymosin market. QY Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Thymosin market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.

Get PDF Sample Copy of this Report including (Product, Summary, TOC, TOF, Industry analysis, Chart)

https://www.qyresearch.com/sample-form/form/1606555/global-thymosin-industry

As part of competitive analysis, the research study includes exhaustive company profiling of leading players of the global Thymosin market. All of the segments studied in the report are analyzed based on different factors such as market share, revenue, and CAGR. The analysts have also thoroughly analyzed different regions such as North America, Europe, and the Asia Pacific on the basis of production, revenue, and sales in the global Thymosin market. The researchers used advanced primary and secondary research methodologies and tools for preparing this report on the global Thymosin market.

Segmentation by Type:

, Thymosin Alpha-1, Thymosin Alpha-2, Thymosin Beta-4

Segmentation by Application:

, Emphysema, Motor Neurone Disease, Malnutrition, Diabetes, Infection, Cancer, Hair Loss, Wound Healing, Other

Competitive Landscape

It is important for every market participant to be familiar with the competitive scenario in the global Thymosin industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key companies operating in the global Thymosin market include , Roche, Leadiant Biosciences, SciClone, Merck, Sclavo, AdiStem, Lee Pharma, Abbiotec, Shanghai Soho-Yiming Pharmaceuticals, Hybio Pharmaceutical, Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical, Jiangsu Haosen Pharmaceutical Group, Beijing Northland Biotechnology, Changchun Jinsai Pharmaceutical, Harbin Pharmaceutical Group Bioengineering, Chengdu Shengnuo Biopharmaceutical, Chengdu Diao Jiuhong Pharmaceutical Factory, Hainan Zhonghe Pharmaceutical, Hainan Shuangcheng Pharmaceutical, Wuxi Kaifu Pharmaceutical, Hunan Yige Pharmaceutical, Xi an Disai bio-pharmaceutical, Jilin Connell Pharmaceutical, Harbin High-Tech Group Baitianer Pharmaceutical, Heilongjiang Xiren Pharmaceutical Group, Heilongjiang Dilong Pharmaceutical, Shanghai Baolong Pharmaceutical Market Segment by Type, Thymosin Alpha-1, Thymosin Alpha-2, Thymosin Beta-4 Market Segment by Application, Emphysema, Motor Neurone Disease, Malnutrition, Diabetes, Infection, Cancer, Hair Loss, Wound Healing, Other Research Methodology To compile the detailed study of the global Thymosin market, a robust research methodology has been adopted that aids in determining the key insights and also evaluates the growth prospects of the Thymosin market. QY Research analysts have conducted in-depth primary and secondary research to obtain crucial insights into the Thymosin market. To carry out secondary research, the analysts have collected the information through company annual reports, journals, company press releases, and paid databases that were referred to gain and identify better opportunities in the global market.

Table of Contents

1 Report Overview1.1 Research Scope1.2 Top Thymosin Manufacturers Covered: Ranking by Revenue1.3 Market Segment by Type1.3.1 Global Thymosin Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)1.3.2 Thymosin Alpha-11.3.3 Thymosin Alpha-21.3.4 Thymosin Beta-41.4 Market Segment by Application1.4.1 Global Thymosin Consumption by Application: 2015 VS 2020 VS 20261.4.2 Emphysema1.4.3 Motor Neurone Disease1.4.4 Malnutrition1.4.5 Diabetes1.4.6 Infection1.4.7 Cancer1.4.8 Hair Loss1.4.9 Wound Healing1.4.10 Other1.5 Study Objectives1.6 Years Considered 2 Global Market Perspective2.1 Global Thymosin Revenue (2015-2026)2.1.1 Global Thymosin Revenue (2015-2026)2.1.2 Global Thymosin Sales (2015-2026)2.2 Thymosin Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 20262.2.1 Global Thymosin Sales by Regions (2015-2020)2.2.2 Global Thymosin Revenue by Regions (2015-2020)2.3 Global Top Thymosin Regions (Countries) Ranking by Market Size2.4 Thymosin Industry Trends2.4.1 Thymosin Market Top Trends2.4.2 Market Drivers2.4.3 Thymosin Market Challenges2.4.4 Porters Five Forces Analysis2.4.5 Primary Interviews with Key Thymosin Players: Views for Future 3 Competitive Landscape by Manufacturers3.1 Global Top Thymosin Manufacturers by Sales (2015-2020)3.1.1 Global Thymosin Sales by Manufacturers (2015-2020)3.1.2 Global Thymosin Sales Market Share by Manufacturers (2015-2020)3.1.3 Global 5 and 10 Largest Manufacturers by Thymosin Sales in 20193.2 Global Top Manufacturers Thymosin by Revenue3.2.1 Global Thymosin Revenue by Manufacturers (2015-2020)3.2.2 Global Thymosin Revenue Share by Manufacturers (2015-2020)3.2.3 Global Thymosin Market Concentration Ratio (CR5 and HHI)3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Thymosin as of 2019)3.4 Global Thymosin Average Selling Price (ASP) by Manufacturers3.5 Key Manufacturers Thymosin Plants/Factories Distribution and Area Served3.6 Date of Key Manufacturers Enter into Thymosin Market3.7 Key Manufacturers Thymosin Product Offered3.8 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type4.1 Global Thymosin Historic Market Review by Type (2015-2020)4.1.2 Global Thymosin Sales Market Share by Type (2015-2020)4.1.3 Global Thymosin Revenue Market Share by Type (2015-2020)4.1.4 Thymosin Price by Type (2015-2020)4.1 Global Thymosin Market Estimates and Forecasts by Type (2021-2026)4.2.2 Global Thymosin Sales Forecast by Type (2021-2026)4.2.3 Global Thymosin Revenue Forecast by Type (2021-2026)4.2.4 Thymosin Price Forecast by Type (2021-2026) 5 Global Thymosin Market Size by Application5.1 Global Thymosin Historic Market Review by Application (2015-2020)5.1.2 Global Thymosin Sales Market Share by Application (2015-2020)5.1.3 Global Thymosin Revenue Market Share by Application (2015-2020)5.1.4 Thymosin Price by Application (2015-2020)5.2 Global Thymosin Market Estimates and Forecasts by Application (2021-2026)5.2.2 Global Thymosin Sales Forecast by Application (2021-2026)5.2.3 Global Thymosin Revenue Forecast by Application (2021-2026)5.2.4 Thymosin Price Forecast by Application (2021-2026) 6 North America6.1 North America Thymosin Breakdown Data by Company6.2 North America Thymosin Breakdown Data by Type6.3 North America Thymosin Breakdown Data by Application6.4 North America Thymosin Breakdown Data by Countries6.4.1 North America Thymosin Sales by Countries6.4.2 North America Thymosin Revenue by Countries6.4.3 U.S.6.4.4 Canada 7 Europe7.1 Europe Thymosin Breakdown Data by Company7.2 Europe Thymosin Breakdown Data by Type7.3 Europe Thymosin Breakdown Data by Application7.4 Europe Thymosin Breakdown Data by Countries7.4.1 Europe Thymosin Sales by Countries7.4.2 Europe Thymosin Revenue by Countries7.4.3 Germany7.4.4 France7.4.5 U.K.7.4.6 Italy7.4.7 Russia 8 Asia Pacific8.1 Asia Pacific Thymosin Breakdown Data by Company8.2 Asia Pacific Thymosin Breakdown Data by Type8.3 Asia Pacific Thymosin Breakdown Data by Application8.4 Asia Pacific Thymosin Breakdown Data by Regions8.4.1 Asia Pacific Thymosin Sales by Regions8.4.2 Asia Pacific Thymosin Revenue by Regions8.4.3 China8.4.4 Japan8.4.5 South Korea8.4.6 India8.4.7 Australia8.4.8 Taiwan8.4.9 Indonesia8.4.10 Thailand8.4.11 Malaysia8.4.12 Philippines8.4.13 Vietnam 9 Latin America9.1 Latin America Thymosin Breakdown Data by Company9.2 Latin America Thymosin Breakdown Data by Type9.3 Latin America Thymosin Breakdown Data by Application9.4 Latin America Thymosin Breakdown Data by Countries9.4.1 Latin America Thymosin Sales by Countries9.4.2 Latin America Thymosin Revenue by Countries9.4.3 Mexico9.4.4 Brazil9.4.5 Argentina 10 Middle East and Africa10.1 Middle East and Africa Thymosin Breakdown Data by Type10.2 Middle East and Africa Thymosin Breakdown Data by Application10.3 Middle East and Africa Thymosin Breakdown Data by Countries10.3.1 Middle East and Africa Thymosin Sales by Countries10.3.2 Middle East and Africa Thymosin Revenue by Countries10.3.3 Turkey10.3.4 Saudi Arabia10.3.5 UAE 11 Company Profiles11.1 Roche11.1.1 Roche Corporation Information11.1.2 Roche Business Overview and Total Revenue (2019 VS 2018)11.1.3 Roche Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.1.4 Roche Thymosin Products and Services11.1.5 Roche SWOT Analysis11.1.6 Roche Recent Developments11.2 Leadiant Biosciences11.2.1 Leadiant Biosciences Corporation Information11.2.2 Leadiant Biosciences Business Overview and Total Revenue (2019 VS 2018)11.2.3 Leadiant Biosciences Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.2.4 Leadiant Biosciences Thymosin Products and Services11.2.5 Leadiant Biosciences SWOT Analysis11.2.6 Leadiant Biosciences Recent Developments11.3 SciClone11.3.1 SciClone Corporation Information11.3.2 SciClone Business Overview and Total Revenue (2019 VS 2018)11.3.3 SciClone Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.3.4 SciClone Thymosin Products and Services11.3.5 SciClone SWOT Analysis11.3.6 SciClone Recent Developments11.4 Merck11.4.1 Merck Corporation Information11.4.2 Merck Business Overview and Total Revenue (2019 VS 2018)11.4.3 Merck Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.4.4 Merck Thymosin Products and Services11.4.5 Merck SWOT Analysis11.4.6 Merck Recent Developments11.5 Sclavo11.5.1 Sclavo Corporation Information11.5.2 Sclavo Business Overview and Total Revenue (2019 VS 2018)11.5.3 Sclavo Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.5.4 Sclavo Thymosin Products and Services11.5.5 Sclavo SWOT Analysis11.5.6 Sclavo Recent Developments11.6 AdiStem11.6.1 AdiStem Corporation Information11.6.2 AdiStem Business Overview and Total Revenue (2019 VS 2018)11.6.3 AdiStem Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.6.4 AdiStem Thymosin Products and Services11.6.5 AdiStem SWOT Analysis11.6.6 AdiStem Recent Developments11.7 Lee Pharma11.7.1 Lee Pharma Corporation Information11.7.2 Lee Pharma Business Overview and Total Revenue (2019 VS 2018)11.7.3 Lee Pharma Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.7.4 Lee Pharma Thymosin Products and Services11.7.5 Lee Pharma SWOT Analysis11.7.6 Lee Pharma Recent Developments11.8 Abbiotec11.8.1 Abbiotec Corporation Information11.8.2 Abbiotec Business Overview and Total Revenue (2019 VS 2018)11.8.3 Abbiotec Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.8.4 Abbiotec Thymosin Products and Services11.8.5 Abbiotec SWOT Analysis11.8.6 Abbiotec Recent Developments11.9 Shanghai Soho-Yiming Pharmaceuticals11.9.1 Shanghai Soho-Yiming Pharmaceuticals Corporation Information11.9.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)11.9.3 Shanghai Soho-Yiming Pharmaceuticals Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.9.4 Shanghai Soho-Yiming Pharmaceuticals Thymosin Products and Services11.9.5 Shanghai Soho-Yiming Pharmaceuticals SWOT Analysis11.9.6 Shanghai Soho-Yiming Pharmaceuticals Recent Developments11.10 Hybio Pharmaceutical11.10.1 Hybio Pharmaceutical Corporation Information11.10.2 Hybio Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)11.10.3 Hybio Pharmaceutical Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.10.4 Hybio Pharmaceutical Thymosin Products and Services11.10.5 Hybio Pharmaceutical SWOT Analysis11.10.6 Hybio Pharmaceutical Recent Developments11.11 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical11.11.1 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Corporation Information11.11.2 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Business Overview and Total Revenue (2019 VS 2018)11.11.3 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.11.4 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Thymosin Products and Services11.11.5 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical SWOT Analysis11.11.6 Suzhou Tianma Pharma Group Tianji Bio-pharmaceutical Recent Developments11.12 Jiangsu Haosen Pharmaceutical Group11.12.1 Jiangsu Haosen Pharmaceutical Group Corporation Information11.12.2 Jiangsu Haosen Pharmaceutical Group Business Overview and Total Revenue (2019 VS 2018)11.12.3 Jiangsu Haosen Pharmaceutical Group Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.12.4 Jiangsu Haosen Pharmaceutical Group Thymosin Products and Services11.12.5 Jiangsu Haosen Pharmaceutical Group SWOT Analysis11.12.6 Jiangsu Haosen Pharmaceutical Group Recent Developments11.13 Beijing Northland Biotechnology11.13.1 Beijing Northland Biotechnology Corporation Information11.13.2 Beijing Northland Biotechnology Business Overview and Total Revenue (2019 VS 2018)11.13.3 Beijing Northland Biotechnology Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.13.4 Beijing Northland Biotechnology Thymosin Products and Services11.13.5 Beijing Northland Biotechnology SWOT Analysis11.13.6 Beijing Northland Biotechnology Recent Developments11.14 Changchun Jinsai Pharmaceutical11.14.1 Changchun Jinsai Pharmaceutical Corporation Information11.14.2 Changchun Jinsai Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)11.14.3 Changchun Jinsai Pharmaceutical Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.14.4 Changchun Jinsai Pharmaceutical Thymosin Products and Services11.14.5 Changchun Jinsai Pharmaceutical SWOT Analysis11.14.6 Changchun Jinsai Pharmaceutical Recent Developments11.15 Harbin Pharmaceutical Group Bioengineering11.15.1 Harbin Pharmaceutical Group Bioengineering Corporation Information11.15.2 Harbin Pharmaceutical Group Bioengineering Business Overview and Total Revenue (2019 VS 2018)11.15.3 Harbin Pharmaceutical Group Bioengineering Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.15.4 Harbin Pharmaceutical Group Bioengineering Thymosin Products and Services11.15.5 Harbin Pharmaceutical Group Bioengineering SWOT Analysis11.15.6 Harbin Pharmaceutical Group Bioengineering Recent Developments11.16 Chengdu Shengnuo Biopharmaceutical11.16.1 Chengdu Shengnuo Biopharmaceutical Corporation Information11.16.2 Chengdu Shengnuo Biopharmaceutical Business Overview and Total Revenue (2019 VS 2018)11.16.3 Chengdu Shengnuo Biopharmaceutical Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.16.4 Chengdu Shengnuo Biopharmaceutical Thymosin Products and Services11.16.5 Chengdu Shengnuo Biopharmaceutical SWOT Analysis11.16.6 Chengdu Shengnuo Biopharmaceutical Recent Developments11.17 Chengdu Diao Jiuhong Pharmaceutical Factory11.17.1 Chengdu Diao Jiuhong Pharmaceutical Factory Corporation Information11.17.2 Chengdu Diao Jiuhong Pharmaceutical Factory Business Overview and Total Revenue (2019 VS 2018)11.17.3 Chengdu Diao Jiuhong Pharmaceutical Factory Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.17.4 Chengdu Diao Jiuhong Pharmaceutical Factory Thymosin Products and Services11.17.5 Chengdu Diao Jiuhong Pharmaceutical Factory SWOT Analysis11.17.6 Chengdu Diao Jiuhong Pharmaceutical Factory Recent Developments11.18 Hainan Zhonghe Pharmaceutical11.18.1 Hainan Zhonghe Pharmaceutical Corporation Information11.18.2 Hainan Zhonghe Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)11.18.3 Hainan Zhonghe Pharmaceutical Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.18.4 Hainan Zhonghe Pharmaceutical Thymosin Products and Services11.18.5 Hainan Zhonghe Pharmaceutical SWOT Analysis11.18.6 Hainan Zhonghe Pharmaceutical Recent Developments11.19 Hainan Shuangcheng Pharmaceutical11.19.1 Hainan Shuangcheng Pharmaceutical Corporation Information11.19.2 Hainan Shuangcheng Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)11.19.3 Hainan Shuangcheng Pharmaceutical Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.19.4 Hainan Shuangcheng Pharmaceutical Thymosin Products and Services11.19.5 Hainan Shuangcheng Pharmaceutical SWOT Analysis11.19.6 Hainan Shuangcheng Pharmaceutical Recent Developments11.20 Wuxi Kaifu Pharmaceutical11.20.1 Wuxi Kaifu Pharmaceutical Corporation Information11.20.2 Wuxi Kaifu Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)11.20.3 Wuxi Kaifu Pharmaceutical Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.20.4 Wuxi Kaifu Pharmaceutical Thymosin Products and Services11.20.5 Wuxi Kaifu Pharmaceutical SWOT Analysis11.20.6 Wuxi Kaifu Pharmaceutical Recent Developments11.21 Hunan Yige Pharmaceutical11.21.1 Hunan Yige Pharmaceutical Corporation Information11.21.2 Hunan Yige Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)11.21.3 Hunan Yige Pharmaceutical Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.21.4 Hunan Yige Pharmaceutical Thymosin Products and Services11.21.5 Hunan Yige Pharmaceutical SWOT Analysis11.21.6 Hunan Yige Pharmaceutical Recent Developments11.22 Xi an Disai bio-pharmaceutical11.22.1 Xi an Disai bio-pharmaceutical Corporation Information11.22.2 Xi an Disai bio-pharmaceutical Business Overview and Total Revenue (2019 VS 2018)11.22.3 Xi an Disai bio-pharmaceutical Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.22.4 Xi an Disai bio-pharmaceutical Thymosin Products and Services11.22.5 Xi an Disai bio-pharmaceutical SWOT Analysis11.22.6 Xi an Disai bio-pharmaceutical Recent Developments11.23 Jilin Connell Pharmaceutical11.23.1 Jilin Connell Pharmaceutical Corporation Information11.23.2 Jilin Connell Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)11.23.3 Jilin Connell Pharmaceutical Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.23.4 Jilin Connell Pharmaceutical Thymosin Products and Services11.23.5 Jilin Connell Pharmaceutical SWOT Analysis11.23.6 Jilin Connell Pharmaceutical Recent Developments11.24 Harbin High-Tech Group Baitianer Pharmaceutical11.24.1 Harbin High-Tech Group Baitianer Pharmaceutical Corporation Information11.24.2 Harbin High-Tech Group Baitianer Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)11.24.3 Harbin High-Tech Group Baitianer Pharmaceutical Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.24.4 Harbin High-Tech Group Baitianer Pharmaceutical Thymosin Products and Services11.24.5 Harbin High-Tech Group Baitianer Pharmaceutical SWOT Analysis11.24.6 Harbin High-Tech Group Baitianer Pharmaceutical Recent Developments11.25 Heilongjiang Xiren Pharmaceutical Group11.25.1 Heilongjiang Xiren Pharmaceutical Group Corporation Information11.25.2 Heilongjiang Xiren Pharmaceutical Group Business Overview and Total Revenue (2019 VS 2018)11.25.3 Heilongjiang Xiren Pharmaceutical Group Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.25.4 Heilongjiang Xiren Pharmaceutical Group Thymosin Products and Services11.25.5 Heilongjiang Xiren Pharmaceutical Group SWOT Analysis11.25.6 Heilongjiang Xiren Pharmaceutical Group Recent Developments11.26 Heilongjiang Dilong Pharmaceutical11.26.1 Heilongjiang Dilong Pharmaceutical Corporation Information11.26.2 Heilongjiang Dilong Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)11.26.3 Heilongjiang Dilong Pharmaceutical Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.26.4 Heilongjiang Dilong Pharmaceutical Thymosin Products and Services11.26.5 Heilongjiang Dilong Pharmaceutical SWOT Analysis11.26.6 Heilongjiang Dilong Pharmaceutical Recent Developments11.27 Shanghai Baolong Pharmaceutical11.27.1 Shanghai Baolong Pharmaceutical Corporation Information11.27.2 Shanghai Baolong Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)11.27.3 Shanghai Baolong Pharmaceutical Thymosin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)11.27.4 Shanghai Baolong Pharmaceutical Thymosin Products and Services11.27.5 Shanghai Baolong Pharmaceutical SWOT Analysis11.27.6 Shanghai Baolong Pharmaceutical Recent Developments 12 Supply Chain and Sales Channels Analysis12.1 Supply Chain Analysis12.2 Sales Channels Analysis12.2.1 Thymosin Sales Channels12.2.2 Thymosin Distributors12.3 Thymosin Customers 13 Estimates and Projections by Regions (2021-2026)13.1 Global Thymosin Sales Forecast (2021-2026)13.1.1 Global Thymosin Sales Forecast by Regions (2021-2026)13.1.2 Global Thymosin Revenue Forecast by Regions (2021-2026)13.2 North America Market Size Forecast (2021-2026)13.2.1 North America Thymosin Sales Forecast (2021-2026)13.2.2 North America Thymosin Revenue Forecast (2021-2026)13.2.3 North America Thymosin Size Forecast by County (2021-2026)13.3 Europe Market Size Forecast (2021-2026)13.3.1 Europe Thymosin Sales Forecast (2021-2026)13.3.2 Europe Thymosin Revenue Forecast (2021-2026)13.3.3 Europe Thymosin Size Forecast by County (2021-2026)13.4 Asia Pacific Market Size Forecast (2021-2026)13.4.1 Asia Pacific Thymosin Sales Forecast (2021-2026)13.4.2 Asia Pacific Thymosin Revenue Forecast (2021-2026)13.4.3 Asia Pacific Thymosin Size Forecast by Region (2021-2026)13.5 Latin America Market Size Forecast (2021-2026)13.5.1 Latin America Thymosin Sales Forecast (2021-2026)13.5.2 Latin America Thymosin Revenue Forecast (2021-2026)13.5.3 Latin America Thymosin Size Forecast by County (2021-2026)13.6 Middle East and Africa Market Forecast13.6.1 Middle East and Africa Thymosin Sales Forecast (2021-2026)13.6.2 Middle East and Africa Thymosin Revenue Forecast (2021-2026)13.6.3 Middle East and Africa Thymosin Size Forecast by County (2021-2026) 14 Research Findings and Conclusion 15 Appendix15.1 Research Methodology15.1.1 Methodology/Research Approach15.1.2 Data Source15.2 Author Details15.3 Disclaimer

Enquire for customization in Report @

https://www.qyresearch.com/customize-request/form/1606555/global-thymosin-industry

Report Objectives

To carefully analyze and estimate the size of the global Thymosin market. To clearly segment the global Thymosin market and estimate the market size of the segments. To provide details about key strategies adopted by leading players of the global Thymosin market. To help readers understand the current and future market scenarios. To provide information about the latest trends of the global Thymosin market and its key segments. To assess the contribution of each region or country to the global Thymosin market. To provide information on important drivers, restraints, and opportunities of the global Thymosin market. To accurately calculate the market shares of key segments, regions, and companies in the global Thymosin market.

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.

Continue reading here:
Thymosin Market Size, Key Trends, Challenges and Standardization, Research, Key Players, Economic Impact and Forecast to 2026| Leadiant Biosciences,...

EVANSTON, Ill. National Merit Scholarship Corporation (NMSC) on May 13 announced this years National Merit $2,500 Scholarship winners.

The 2,500 Merit Scholar designees were chosen from a talent pool of more than 15,000 outstanding finalists in the 2020 National Merit Scholarship Program.

Evelyn Hasama and Summer Hasama

National Merit $2,500 Scholarship winners are the finalists in each state judged to have the strongest combination of accomplishments, skills, and potential for success in rigorous college studies. The number of winners named in each state is proportional to the states percentage of the nations graduating high school seniors.

These scholars were selected by a committee of college admissions officers and high school counselors, who appraised a substantial amount of information submitted by both the finalists and their high schools: the academic record, including difficulty level of subjects studied and grades earned; scores from the Preliminary SAT/National Merit Scholarship Qualifying Test (PSAT/NMSQT); contributions and leadership in school and community activities; an essay written by the finalist; and a recommendation written by a high school official.

This is the second announcement of winners in the 2020 National Merit Scholarship Program. On April 22, more than 1,000 recipients of corporate-sponsored Merit Scholarship awards were named, and on June 3 and July 13, some 4,100 college-sponsored Merit Scholarship winners will be announced. By the conclusion of this years competition, about 7,600 academic champions will have won National Merit Scholarships worth more than $30 million.

For more information, visit http://www.nationalmerit.org.

California winners of National Merit $2,500 Scholarship include the following.

Kyle M. Tsujimotoof Cupertino. Probable career field: Medicine. Monta Vista High School, Cupertino. This award is supported by NMSCs own funds.

Wren E. Kawamuraof La Caada. Probable career field: Applied mathematics. La Caada High School, La Caada Flintridge. This award is supported by NMSCs own funds.

Ryan J. Kawaharaof Los Altos. Probable career field: Media. St. Francis High School, Mountain View. Scholarship underwritten by Sony Electronics Inc., which supports this scholarship as part of its commitment to higher education.

Kylie L. Akiyamaof Los Altos Hills. Probable career field: Bioengineering. Los Altos High School, Los Altos. This award is supported by NMSCs own funds.

Evelyn H. Hasamaof Rancho Palos Verdes. Probable career field: Software engineering. Palos Verdes Peninsula High School, Rollling Hills Estates. This award is supported by NMSCs own funds.

Summer M. Hasamaof Rancho Palos Verdes. Probable career field: Undecided. Palos Verdes Peninsula High School, Rolling Hills Estates. This award is supported by NMSCs own funds.

Emika G. Saitoof Temecula. Probable career field: Biomedical engineering. Great Oak High School, Temecula. This award is supported by NMSCs own funds.

Tags

More:
National Merit $2,500 Scholarship Winners Announced - The Rafu Shimpo

An academic army has assembled in the Bay Area over the past several weeks, shifting research efforts to combat the coronavirus and its far-reaching impact.

The endeavor, composed of thousands of scientists, researchers and scholars, is a historic and virtually unheard of effort, with some of the biggest brains in the world dropping whatever they were working on to focus their expertise on the disease.

The Bay Area, home to one of the highest concentrations of Nobel laureates and advanced degrees, has become a hub of coronavirus activity. The efforts so far include a technique to make medical masks modeled after cotton-candy machines, an algorithm to search billions of tweets for signs of community clusters of coronavirus-fueled depression and an early-detection system to locate COVID-19 conspiracies and misinformation on social media.

As engineers and scientists, we take the oath, said Manu Prakash, a bioengineering professor at Stanford University, who worked on the cotton-candy medical mask concept. When there is a challenge, if were not going to rise to the occasion, who else is going to solve these problems?

The crisis has created an environment of cooperation and communal sharing of discoveries and ideas, which is very rare in the scientific community. Scientists and researchers, often at competitive odds, typically guard their studies and discoveries from their peers until they can claim credit.

Research and discovery, which can take years to fund and execute under normal circumstances, is taking weeks, with international cooperation fueling progress and funders fast-tracking grants.

The global crisis has spurred an unprecedented call to action in academia, experts say.

A lot of the finest minds of the world have turned to COVID-19, said Hany Farid, UC Berkeley computer science professor.

Their efforts are already paying off.

Prakash had just returned to Stanford University in early March from a scuba diving trip in France where the coronavirus was already hitting hard and immediately went into quarantine in his room.

The bioengineer had seen the fallout of the disease in Europe and anticipated impending doom in the U.S., with shortages of protective medical gear. Confined with his possessions, he stared at the full-face snorkel mask that he hadnt stored away after the trip.

What if, he thought, it could be converted into a reusable medical mask? As he waited for any symptoms to show up, he got to work, designing a way to attach viral filters. It worked, tested to function at the highest standards. The goal now is to work with a coalition of partners to produce 50,000 reusable Pneumasks for distribution around the world, with a $20 to $30 cost to produce each one.

His Stanford lab focuses on frugal science, or research focused on ways for even the poorest communities to access health care and other resources, including a 50-cent, paper microscope.

The coronavirus has created an urgency to this work, he said, an exclamation point on the expression, Necessity is the mother of invention.

All my students are working on these projects, he said. Theyve dropped everything to engage.

Farid also shifted his research to the coronavirus. Hes been studying the spread of misinformation and conspiracies on social media for years.

The coronavirus has made past conspiracy theories and disinformation campaigns look small by comparison. This is global, people are scared, and they are on social media, he said.

The perfect sstorm, he said.

This is why we have people drinking bleach thinking theyre going to be cured, Farid said, referring to social media posts recommending the dangerous idea. We need to undo the stupidity thats out there.

Farid developed a large survey last week, asking 500 people to read 40 coronavirus-related headlines, 20 not true, 20 true, asking if they had seen them, believed them, or knew someone who would believe them.

Preliminary results shows 15% of those surveyed said they know someone who would believe that gargling bleach to prevent or cure coronavirus was legitimate.

Thats shocking, he said. Now the question is whats next.

Farid is developing early detection systems to identify these types of conspiracies or misinformation campaigns online and flag it for social media companies.

We have to be able to disrupt these campaigns at the beginning, he said.

Coronavirus has been a call to arms, said Julia Schaletzky, executive director of the UC Berkeley Center for Emerging and Neglected Diseases.

Everybody has eyes on goal, she said. Its kind of amazing to see that.

Schaletzky used her fundraising skills to create a $1 million COVID catalyst fund to seed research without the usual long application and review process. The first batch of cash went out Thursday, funding researchers working on an at-home coronavirus diagnostic based on an agricultural testing tool.

I havent had a weekend since we started and the same is true for most of my colleagues, she said. Everybody is trying, and there is a true commitment to do something about this disease.

Johannes Eichstaedt, a Stanford assistant professor in psychology, is also looking to mitigate the effects of the virus, tracking the digital traces of depression, despair and other psychological impacts of the coronavirus.

The idea is to detect hot spots of mental health crisis in communities or counties, to create some visibility into these psychological shifts, he said. The general assumption is that you can only improve what you can measure.

His algorithm is sweeping billions of tweets.

The algorithm is currently analyzing the prevalence of 10,000 words, phrases and emojis, words like alone, expressions of hostility, cursing, anger, complaining about headaches or their bodies.

The results could help push for federal or local emergency funding to direct more therapists or mental health resources into communities, Eichstaedt said.

Lots of people are going to struggle a lot, he said. Im not sure we are helping them.

Experts around the world, say the current crisis is a novel moment in human history, a global laboratory ripe for research and solutions to a host of problems related to the virus.

This is the bread and butter of the life of a researcher, Farid said. This is what we do every day, except now were just doing it in a crisis-mode situation.

An earlier version of this story incorrectly stated the type of mask converted for medical purposes.

Jill Tucker is a San Francisco Chronicle staff writer. Email: jtucker@sfchronicle.com Twitter: @jilltucker

Follow this link:
'The finest minds in the world': Bay Area researchers race to fight coronavirus with innovation and creativity - San Francisco Chronicle

The latest report onUltrafiltration Membrane Filtration Marketgives a broad assessment of the global Ultrafiltration Membrane Filtration market by categorizing it in terms applications, types, and regions. The report gives a detailed analysis on competitive landscape and strategies that influenced the market in a positive way. Further, the report gives an overview of current market dynamics by studying various key segments based on the product, types, applications, end-to-end industries and market scenario.

Request a sample of this report @https://www.globalmarketers.biz/report/chemicals-and-materials/2015-2027-global-ultrafiltration-membrane-filtration-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/145616#request_sample

Major Key Playersof Ultrafiltration Membrane Filtration Market Report:

Degremont Technologies3M (Membrana)Microdyn-NadirPentair(X-Flow)Origin WaterMitsubishi RayonSynder FiltrationCITIC EnvirotechApplied MembranesTorayKochAsahi KaseiZhaojin MotianDOWTianjin MOTIMOBasfMemsinoLitreeCanpureNitto Denko CorporationEvoquaGE Water & Process Technologies

Scope of the Ultrafiltration Membrane Filtration Market Report:

Ultrafiltration Membrane Filtration market research report focuses on demand and supply analysis at the global regional and domestic level. Considering the global perspective, the report presents overall Ultrafiltration Membrane Filtration market by size by analyzing historical data and future prospective. The report focuses on several key regions includingNorth America, Europe, Asia-Pacific and RoW.

2020 has been considered as the base year and the report gives market estimation for the period 2020 to 2027. The report studies the worldwide Ultrafiltration Membrane Filtration market (size, capacity, production and consumption) in key regions.

Make an Inquiry About This Report @ https://www.globalmarketers.biz/report/chemicals-and-materials/2015-2027-global-ultrafiltration-membrane-filtration-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/145616#inquiry_before_buying

For product type segment, this report listed main product type of Ultrafiltration Membrane Filtration market

Inorganic MembraneOrganic Membrane

For application segment, this report focuses on the status and outlook for key applications. End users are also listed.

Food & BeverageIndustrial & MunicipalHealthcare & BioengineeringSeawater Reverse OsmosisPotable Water Treatment

Place Inquiry for Buying or Customization of Report:https://www.globalmarketers.biz/inquiry/customization/145616

Furtherin the Ultrafiltration Membrane Filtration Market research reports,followingpoints are included along within-depthstudy of each point:

Supply Chain Analysis Production of the Ultrafiltration Membrane Filtration is analyzed with respect to different regions, types and applications. Here, price and revenue analysis of various Ultrafiltration Membrane Filtration Market key players is also covered.

Demand and Consumption Analysis This part of the report thoroughly studiesdemand and consumption for the Ultrafiltration Membrane Filtration Market. This part also sheds light on the gap between demand supply and consumption pattern throughout the globe. Import and export analysis are also given in this part.

Key Strategic DevelopmentsThe study also includes the key strategic developments of the Ultrafiltration Membrane Filtration market, comprising product portfolio, which details production, revenue, price, market share and growth rate on the basis of product diversification. Additionally, the report studies sales volume, market share and growth rate on the basis of applications/end users for each application. The product diversification also includes SWOT and PEST analysis to understand the regional product segmentation market.

Ultrafiltration Membrane FiltrationMarket Report Includes:

Market Outlook:Status and Dynamics.

Competitive Landscape:By Manufacturers, Vendors and Development Trends.

Product Revenue for Top Players:Market Share, Size, CAGR, Current Market Situation Analysis, Future Market Forecast for the next 5 years period.

Market Segmentation:By Types, By Applications, By End-Users, By Regions/ Geography.

Sales Revenue:Market Share, Price and Cost Analysis, Growth Rate, Current Market Analysis.

Check Table of Contents of This Report @ https://www.globalmarketers.biz/report/chemicals-and-materials/2015-2027-global-ultrafiltration-membrane-filtration-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/145616#table_of_contents

Benefits of Purchasing Ultrafiltration Membrane Filtration Market Report:

Analyst Support:Get your query fixed from our expert analysts before and after buying the report.

Customers Satisfaction:Our expert team will assist you with all your research needs and customize the report.

Incomparable Expertise:Analysts will provide deep understandings into the reports.

Assured Quality:We focus on the quality and accuracy of the report.

View original post here:
Global Ultrafiltration Membrane Filtration Market Analysis, Technologies, Future Guidelines and Forecasts Report 2027 - Cole of Duty

LEFT: Kyle Schwab, a graduate bioengineering student, works on the molds used to create protective face shields. | JACK OSWALD / COURTESY | RIGHT: A row of face shields created by a task force of Temple students, faculty and staff for healthcare workers. | TEMPLE ENGINEERING / COURTESY

A team of Temple University faculty, staff and students continue to produce hundreds of face shields each day for workers in Temple University Hospital amid the COVID-19 pandemic.

As of Monday, 2,000 shields had been delivered to TUH with hundreds more ready to be sent off, said Michael Kalai, the senior director of technology and operations in the College of Engineering who leads the project.

Temples task force is averaging approximately 500 shields per day and expects to deliver 1,000 to TUH and another 500 to the Kornberg School of Dentistry this week, Kalai said. It costs approximately $1.25 to manufacture each shield.

The team will make 15,000 shields in total before it reassesses whether more need to be produced, Kalai added. Donating the shields to other area hospitals is an option if TUH says it has enough, he said.

The reusable shields, which were previously 3D printed but now are all assembled by hand, Kalai said, act as personal protective equipment for TUH staff, a commodity which is in short supply around the country as COVID-19 patients continue to overwhelm hospitals, TIME reported.

The work they are doing is critical in the effort to keep our employees and front line staff safe and protected, said Abhinav Rastogi, the senior vice president of professional services at Temple University Hospital, in a statement. Together we will continue to keep creating innovative solutions for our organization and others during this difficult time.

The task force is comprised of faculty and students from bioengineering and mechanical engineering as well as faculty from the College of Science and Technology, the Tyler School of Art and Architecture, Temple Libraries, Student Health Services, the Office for the Vice President for Research, Information Technology Services and Campus Operations, The Temple News reported.

Read the original:
Temple ramps up production of protective face shields - Temple News

Given the debilitating impact of COVID-19 (Coronavirus) on the Cholic Acid market, companies are vying opportunities to stay afloat in the market landscape. Gain access to our latest research analysis on COVID-19 associated with the Cholic Acid market and understand how market players are adopting new strategies to mitigate the impact of the pandemic.

The report provides both quantitative and qualitative information of global Cholic Acid market for period of 2018 to 2025. As per the analysis provided in the report, the global market of Cholic Acid is estimated to growth at a CAGR of _% during the forecast period 2018 to 2025 and is expected to rise to USD _ million/billion by the end of year 2025. In the year 2016, the global Cholic Acid market was valued at USD _ million/billion.

This research report based on Cholic Acid market and available with Market Study Report includes latest and upcoming industry trends in addition to the global spectrum of the Cholic Acid market that includes numerous regions. Likewise, the report also expands on intricate details pertaining to contributions by key players, demand and supply analysis as well as market share growth of the Cholic Acid industry.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/30347

Cholic Acid Market Overview:

The Research projects that the Cholic Acid market size will grow from in 2018 to by 2024, at an estimated CAGR of XX%. The base year considered for the study is 2018, and the market size is projected from 2018 to 2024.

Leading manufacturers of Cholic Acid Market:

key players across the value chain of cholic acid market are Merck KGaA, Alchem International Pvt. Ltd., Dr. Falk Pharma GmbH., Suzhou Tianlu Bio-pharmaceutical Co., Ltd., Zhongshan Belling Biotechnology Co.,Ltd., Shanghai Tauto Biotech Co., Ltd., MANUS AKTTEVA, Dipharma Francis Srl., ANHUI CHEM-BRIGHT BIOENGINEERING CO.,LTD and others.

The report on Cholic acid market covers exhaustive analysis on:

Regional analysis for Cholic acid market includes

Report on Cholic acid market highlights:

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/30347

Some important highlights from the report include:

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/30347

The Questions Answered by Cholic Acid Market Report:

And Many More.

Read the original post:
The Economic Impact of Coronavirus on Cholic Acid Market Set To Register A CAGR Growth Of XX% Over The Forecast Period 2019 2029 - Latest Herald

Catastrophic economic damage is pushing world economies to think about how they will rebuild as the COVID-19 coronavirus pandemic eases but new figures suggest the biggest opportunities for Australias recovery will come in areas where the Morrison government has been winding back funding.

The technology areas promising the most impactful innovation in coming years include data and AI, medical bioengineering, trust and supply chains, and the future of work, a new survey of experts by the Atlantic Councils GeoTech Center has revealed.

A non-partisan policy thinktank, the Atlantic Councils analysis concluded that the coronavirus pandemic will accelerate innovation significantly as world economies adjust to the impact of massive changes in long-established models of work and tap new technologies to solve medical and bioengineering problems.

The thirst for innovation had driven efforts such as the use of 3D printing to manufacture protective personal equipment (PPE), with Konica Minolta Australia the latest to jump onboard through a partnership that will see it 3D printing Venturi valves for P2/N95 masks that were designed by partner 3D Systems.

In another local innovation, Australian company SPEE3D announced that it had developed a way of 3D printing its ACTIVAT3D copper coating claimed to kill 96 per cent of SARS-CoV-2 virus within 2 hours onto high-use metal objects such as door handles, hand rails and touch plates.

Western Australian firm Nanoveu has also been addressing coronavirus with innovation, recently reporting that initial testing had shown a purpose-designed antiviral nanotechnology coating would pave the way for smartphone and tablet cases capable of killing viruses on contact.

Innovating on their own

The Atlantic Council experts scored Australia, the UK, Canada, and New Zealand grouped for their similar approach to innovation as having an average innovation impact of 0.72.

This put Australia behind Singapore, Japan and South Korea (0.89) and just behind China (0.77) and the United States (0.76) but well ahead of the EU countries and India/South East Asia, with average innovation scores of 0.58 and 0.42 respectively.

Innovation will not be distributed evenly when it occurs, the analysis notes, either geographically or technologically and the countries manifesting innovation will do so in starkly different fields.

China, for example, would lead the world in terms of innovation around data and AI while EU countries would lead in supply-chain overhauls, Russia would be almost the only country to double down on space technology, and the UK/Canada/ANZ cluster would make the most impact in medical and bioengineering.

Yet in Australia, capitalising on innovation opportunities has traditionally come with the strong backing of government bodies and public-private partnerships whose viability may be tested when the government releases its delayed coronavirus-focused 2020-2021 budget in October.

Business funding to date has been focused on helping maintain the status quo through costly economic hibernation by keeping Australians employed and housed throughout the duration of the lockdown but the nature of that support will need to change for the business community to turn innovation into a net-positive force for economic growth.

That was already a difficult ask, with a recent Harvard University study ranking Australias economic diversification as 93rd in the world down 22 spots between 2007 and 2017 and the Morrison government already controversially cutting R&D funding and slashing innovation programs long before COVID-19 had emerged.

A likely budget focus on paying for coronavirus stimulus could challenge the governments past innovation commitments, such as the $20b Medical Research Future Fund that would if the funding can be preserved seemingly play into the priority areas identified by the Atlantic Council survey.

Time will tell whether Australia can find the money to back innovation as a force for economic rebuilding a goal that the Department of Industry, Science, Energy and Resources identified in its Australia 2030 strategy and whether that innovation will play a large or a marginal role in following other countries as the world eventually pivots into the post-coronavirus era.

While more developed economies will probably continue fuelling innovation alongside their recovery efforts, the Atlantic Council analysis notes, others will not have that luxury.

Accordingly, innovation from more developed economies will likely consist of new technologies shaped by the pandemic and their response that is, innovation and recovery.

Less developed economies may be more prone to innovate by adapting older technologies and systems to better suit their current needs innovation in recovery.

Read the original here:
Will innovation help Australia recover post COVID-19? - ACS

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Wearable Physical Capacity Evaluation System Market which would mention How the Covid-19 is Affecting the Wearable Physical Capacity Evaluation System Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Wearable Physical Capacity Evaluation System Players to Combat Covid-19 Impact.

The Global Wearable Physical Capacity Evaluation System Market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Researchs latest publication, Titled [Wearable Physical Capacity Evaluation System Market Research Report 2020], offers an insightful take on the drivers and restraints present in the market. It assesses the historical data pertaining to the global Wearable Physical Capacity Evaluation System market and compares it to the current market trends to give the readers a detailed analysis of the trajectory of the market. A team subject-matter experts have provided the readers a qualitative and quantitative data about the market and the various elements associated with it.

Key companies operating in the global Wearable Physical Capacity Evaluation Systemmarket include_Hocoma, LiteGait, BTS Bioengineering, MIE Medical Research, Techno Concept, Tekscan, Inc., BioMed Jena, Am Cube, Novel DE, GaitUp, Exel, ReTiSense, Sensor Medica, H/p/cosmos, MediTouch

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1664134/global-wearable-physical-capacity-evaluation-system-market

The Essential Content Covered in the Global Wearable Physical Capacity Evaluation System Market Report:Top Key Company Profiles.Main Business and Rival InformationSWOT Analysis and PESTEL AnalysisProduction, Sales, Revenue, Price and Gross MarginMarket Size And Growth RateCompany Market Share

Segmental Analysis :

The report has classified the global Wearable Physical Capacity Evaluation System industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Wearable Physical Capacity Evaluation System manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Wearable Physical Capacity Evaluation System industry.

Global Wearable Physical Capacity Evaluation System Market Segment By Type:

Posture Analysis System, Gaint Analysis System, Other

Global Wearable Physical Capacity Evaluation System Market Segment By Applications:

Hospital, Clinic, Rehabilitation Centre, Other

Critical questions addressed by the Wearable Physical Capacity Evaluation System Market report

Reasons to Buy the Report

Get Full Customize report now at :https://www.qyresearch.com/customize-request/form/1664134/global-wearable-physical-capacity-evaluation-system-market

Table Of Content

1 Wearable Physical Capacity Evaluation System Market Overview1.1 Wearable Physical Capacity Evaluation System Product Overview1.2 Wearable Physical Capacity Evaluation System Market Segment by Type1.2.1 Posture Analysis System1.2.2 Gaint Analysis System1.2.3 Other1.3 Global Wearable Physical Capacity Evaluation System Market Size by Type (2015-2026)1.3.1 Global Wearable Physical Capacity Evaluation System Market Size Overview by Type (2015-2026)1.3.2 Global Wearable Physical Capacity Evaluation System Historic Market Size Review by Type (2015-2020)1.3.2.1 Global Wearable Physical Capacity Evaluation System Sales Market Share Breakdown by Type (2015-2026)1.3.2.2 Global Wearable Physical Capacity Evaluation System Revenue Market Share Breakdown by Type (2015-2026)1.3.2.3 Global Wearable Physical Capacity Evaluation System Average Selling Price (ASP) by Type (2015-2026)1.3.3 Global Wearable Physical Capacity Evaluation System Market Size Forecast by Type (2021-2026)1.3.3.1 Global Wearable Physical Capacity Evaluation System Sales Market Share Breakdown by Application (2021-2026)1.3.3.2 Global Wearable Physical Capacity Evaluation System Revenue Market Share Breakdown by Application (2021-2026)1.3.3.3 Global Wearable Physical Capacity Evaluation System Average Selling Price (ASP) by Application (2021-2026)1.4 Key Regions Market Size Segment by Type (2015-2020)1.4.1 North America Wearable Physical Capacity Evaluation System Sales Breakdown by Type (2015-2026)1.4.2 Europe Wearable Physical Capacity Evaluation System Sales Breakdown by Type (2015-2026)1.4.3 Asia-Pacific Wearable Physical Capacity Evaluation System Sales Breakdown by Type (2015-2026)1.4.4 Latin America Wearable Physical Capacity Evaluation System Sales Breakdown by Type (2015-2026)1.4.5 Middle East and Africa Wearable Physical Capacity Evaluation System Sales Breakdown by Type (2015-2026)1.5 Coronavirus Disease 2019 (Covid-19): Wearable Physical Capacity Evaluation System Industry Impact1.5.1 How the Covid-19 is Affecting the Wearable Physical Capacity Evaluation System Industry1.5.1.1 Wearable Physical Capacity Evaluation System Business Impact Assessment Covid-191.5.1.2 Supply Chain Challenges1.5.1.3 COVID-19s Impact On Crude Oil and Refined Products1.5.2 Market Trends and Wearable Physical Capacity Evaluation System Potential Opportunities in the COVID-19 Landscape1.5.3 Measures / Proposal against Covid-191.5.3.1 Government Measures to Combat Covid-19 Impact1.5.3.2 Proposal for Wearable Physical Capacity Evaluation System Players to Combat Covid-19 Impact

2 Global Wearable Physical Capacity Evaluation System Market Competition by Company2.1 Global Top Players by Wearable Physical Capacity Evaluation System Sales (2015-2020)2.2 Global Top Players by Wearable Physical Capacity Evaluation System Revenue (2015-2020)2.3 Global Top Players Wearable Physical Capacity Evaluation System Average Selling Price (ASP) (2015-2020)2.4 Global Top Manufacturers Wearable Physical Capacity Evaluation System Manufacturing Base Distribution, Sales Area, Product Type2.5 Wearable Physical Capacity Evaluation System Market Competitive Situation and Trends2.5.1 Wearable Physical Capacity Evaluation System Market Concentration Rate (2015-2020)2.5.2 Global 5 and 10 Largest Manufacturers by Wearable Physical Capacity Evaluation System Sales and Revenue in 20192.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Wearable Physical Capacity Evaluation System as of 2019)2.7 Date of Key Manufacturers Enter into Wearable Physical Capacity Evaluation System Market2.8 Key Manufacturers Wearable Physical Capacity Evaluation System Product Offered2.9 Mergers & Acquisitions, Expansion

3 Global Wearable Physical Capacity Evaluation System Status and Outlook by Region (2015-2026)3.1 Global Wearable Physical Capacity Evaluation System Market Size and CAGR by Region: 2015 VS 2020 VS 20263.2 Global Wearable Physical Capacity Evaluation System Market Size Market Share by Region (2015-2020)3.2.1 Global Wearable Physical Capacity Evaluation System Sales Market Share by Region (2015-2020)3.2.2 Global Wearable Physical Capacity Evaluation System Revenue Market Share by Region (2015-2020)3.2.3 Global Wearable Physical Capacity Evaluation System Sales, Revenue, Price and Gross Margin (2015-2020)3.3 Global Wearable Physical Capacity Evaluation System Market Size Market Share by Region (2021-2026)3.3.1 Global Wearable Physical Capacity Evaluation System Sales Market Share by Region (2021-2026)3.3.2 Global Wearable Physical Capacity Evaluation System Revenue Market Share by Region (2021-2026)3.3.3 Global Wearable Physical Capacity Evaluation System Sales, Revenue, Price and Gross Margin (2021-2026)3.4 North America Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)3.4.1 North America Wearable Physical Capacity Evaluation System Revenue YoY Growth (2015-2026)3.4.2 North America Wearable Physical Capacity Evaluation System Sales YoY Growth (2015-2026)3.5 Asia-Pacific Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)3.5.1 Asia-Pacific Wearable Physical Capacity Evaluation System Revenue YoY Growth (2015-2026)3.5.2 Asia-Pacific Wearable Physical Capacity Evaluation System Sales YoY Growth (2015-2026)3.6 Europe Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)3.6.1 Europe Wearable Physical Capacity Evaluation System Revenue YoY Growth (2015-2026)3.6.2 Europe Wearable Physical Capacity Evaluation System Sales YoY Growth (2015-2026)3.7 Latin America Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)3.7.1 Latin America Wearable Physical Capacity Evaluation System Revenue YoY Growth (2015-2026)3.7.2 Latin America Wearable Physical Capacity Evaluation System Sales YoY Growth (2015-2026)3.8 Middle East and Africa Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)3.8.1 Middle East and Africa Wearable Physical Capacity Evaluation System Revenue YoY Growth (2015-2026)3.8.2 Middle East and Africa Wearable Physical Capacity Evaluation System Sales YoY Growth (2015-2026)

4 Global Wearable Physical Capacity Evaluation System by Application4.1 Wearable Physical Capacity Evaluation System Segment by Application4.1.1 Hospital4.1.2 Clinic4.1.3 Rehabilitation Centre4.1.4 Other4.2 Global Wearable Physical Capacity Evaluation System Sales by Application: 2015 VS 2020 VS 20264.3 Global Wearable Physical Capacity Evaluation System Historic Sales by Application (2015-2020)4.4 Global Wearable Physical Capacity Evaluation System Forecasted Sales by Application (2021-2026)4.5 Key Regions Wearable Physical Capacity Evaluation System Market Size by Application4.5.1 North America Wearable Physical Capacity Evaluation System by Application4.5.2 Europe Wearable Physical Capacity Evaluation System by Application4.5.3 Asia-Pacific Wearable Physical Capacity Evaluation System by Application4.5.4 Latin America Wearable Physical Capacity Evaluation System by Application4.5.5 Middle East and Africa Wearable Physical Capacity Evaluation System by Application5 North America Wearable Physical Capacity Evaluation System Market Size by Country (2015-2026)5.1 North America Market Size Market Share by Country (2015-2020)5.1.1 North America Wearable Physical Capacity Evaluation System Sales Market Share by Country (2015-2020)5.1.2 North America Wearable Physical Capacity Evaluation System Revenue Market Share by Country (2015-2020)5.2 North America Market Size Market Share by Country (2021-2026)5.2.1 North America Wearable Physical Capacity Evaluation System Sales Market Share by Country (2021-2026)5.2.2 North America Wearable Physical Capacity Evaluation System Revenue Market Share by Country (2021-2026)5.3 North America Market Size YoY Growth by Country5.3.1 U.S. Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)5.3.2 Canada Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)6 Europe Wearable Physical Capacity Evaluation System Market Size by Country (2015-2026)6.1 Europe Market Size Market Share by Country (2015-2020)6.1.1 Europe Wearable Physical Capacity Evaluation System Sales Market Share by Country (2015-2020)6.1.2 Europe Wearable Physical Capacity Evaluation System Revenue Market Share by Country (2015-2020)6.2 Europe Market Size Market Share by Country (2021-2026)6.2.1 Europe Wearable Physical Capacity Evaluation System Sales Market Share by Country (2021-2026)6.2.2 Europe Wearable Physical Capacity Evaluation System Revenue Market Share by Country (2021-2026)6.3 Europe Market Size YoY Growth by Country6.3.1 Germany Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)6.3.2 France Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)6.3.3 U.K. Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)6.3.4 Italy Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)6.3.5 Russia Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)7 Asia-Pacific Wearable Physical Capacity Evaluation System Market Size by Country (2015-2026)7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)7.1.1 Asia-Pacific Wearable Physical Capacity Evaluation System Sales Market Share by Country (2015-2020)7.1.2 Asia-Pacific Wearable Physical Capacity Evaluation System Revenue Market Share by Country (2015-2020)7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)7.2.1 Asia-Pacific Wearable Physical Capacity Evaluation System Sales Market Share by Country (2021-2026)7.2.2 Asia-Pacific Wearable Physical Capacity Evaluation System Revenue Market Share by Country (2021-2026)7.3 Asia-Pacific Market Size YoY Growth by Country7.3.1 China Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)7.3.2 Japan Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)7.3.3 South Korea Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)7.3.4 India Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)7.3.5 Australia Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)7.3.6 Taiwan Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)7.3.7 Indonesia Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)7.3.8 Thailand Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)7.3.9 Malaysia Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)7.3.10 Philippines Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)7.3.11 Vietnam Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)8 Latin America Wearable Physical Capacity Evaluation System Market Size by Country (2015-2026)8.1 Latin America Market Size Market Share by Country (2015-2020)8.1.1 Latin America Wearable Physical Capacity Evaluation System Sales Market Share by Country (2015-2020)8.1.2 Latin America Wearable Physical Capacity Evaluation System Revenue Market Share by Country (2015-2020)8.2 Latin America Market Size Market Share by Country (2021-2026)8.2.1 Latin America Wearable Physical Capacity Evaluation System Sales Market Share by Country (2021-2026)8.2.2 Latin America Wearable Physical Capacity Evaluation System Revenue Market Share by Country (2021-2026)8.3 Latin America Market Size YoY Growth by Country8.3.1 Mexico Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)8.3.2 Brazil Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)8.3.3 Argentina Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)9 Middle East and Africa Wearable Physical Capacity Evaluation System Market Size by Country (2015-2026)9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)9.1.1 Middle East and Africa Wearable Physical Capacity Evaluation System Sales Market Share by Country (2015-2020)9.1.2 Middle East and Africa Wearable Physical Capacity Evaluation System Revenue Market Share by Country (2015-2020)9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)9.2.1 Middle East and Africa Wearable Physical Capacity Evaluation System Sales Market Share by Country (2021-2026)9.2.2 Middle East and Africa Wearable Physical Capacity Evaluation System Revenue Market Share by Country (2021-2026)9.3 Middle East and Africa Market Size YoY Growth by Country9.3.1 Turkey Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)9.3.2 Saudi Arabia Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)9.3.3 U.A.E Wearable Physical Capacity Evaluation System Market Size YoY Growth (2015-2026)

10 Company Profiles and Key Figures in Wearable Physical Capacity Evaluation System Business10.1 Hocoma10.1.1 Hocoma Corporation Information10.1.2 Hocoma Description, Business Overview and Total Revenue10.1.3 Hocoma Wearable Physical Capacity Evaluation System Sales, Revenue and Gross Margin (2015-2020)10.1.4 Hocoma Wearable Physical Capacity Evaluation System Products Offered10.1.5 Hocoma Recent Development10.2 LiteGait10.2.1 LiteGait Corporation Information10.2.2 LiteGait Description, Business Overview and Total Revenue10.2.3 LiteGait Wearable Physical Capacity Evaluation System Sales, Revenue and Gross Margin (2015-2020)10.2.4 Hocoma Wearable Physical Capacity Evaluation System Products Offered10.2.5 LiteGait Recent Development10.3 BTS Bioengineering10.3.1 BTS Bioengineering Corporation Information10.3.2 BTS Bioengineering Description, Business Overview and Total Revenue10.3.3 BTS Bioengineering Wearable Physical Capacity Evaluation System Sales, Revenue and Gross Margin (2015-2020)10.3.4 BTS Bioengineering Wearable Physical Capacity Evaluation System Products Offered10.3.5 BTS Bioengineering Recent Development10.4 MIE Medical Research10.4.1 MIE Medical Research Corporation Information10.4.2 MIE Medical Research Description, Business Overview and Total Revenue10.4.3 MIE Medical Research Wearable Physical Capacity Evaluation System Sales, Revenue and Gross Margin (2015-2020)10.4.4 MIE Medical Research Wearable Physical Capacity Evaluation System Products Offered10.4.5 MIE Medical Research Recent Development10.5 Techno Concept10.5.1 Techno Concept Corporation Information10.5.2 Techno Concept Description, Business Overview and Total Revenue10.5.3 Techno Concept Wearable Physical Capacity Evaluation System Sales, Revenue and Gross Margin (2015-2020)10.5.4 Techno Concept Wearable Physical Capacity Evaluation System Products Offered10.5.5 Techno Concept Recent Development10.6 Tekscan, Inc.10.6.1 Tekscan, Inc. Corporation Information10.6.2 Tekscan, Inc. Description, Business Overview and Total Revenue10.6.3 Tekscan, Inc. Wearable Physical Capacity Evaluation System Sales, Revenue and Gross Margin (2015-2020)10.6.4 Tekscan, Inc. Wearable Physical Capacity Evaluation System Products Offered10.6.5 Tekscan, Inc. Recent Development10.7 BioMed Jena10.7.1 BioMed Jena Corporation Information10.7.2 BioMed Jena Description, Business Overview and Total Revenue10.7.3 BioMed Jena Wearable Physical Capacity Evaluation System Sales, Revenue and Gross Margin (2015-2020)10.7.4 BioMed Jena Wearable Physical Capacity Evaluation System Products Offered10.7.5 BioMed Jena Recent Development10.8 Am Cube10.8.1 Am Cube Corporation Information10.8.2 Am Cube Description, Business Overview and Total Revenue10.8.3 Am Cube Wearable Physical Capacity Evaluation System Sales, Revenue and Gross Margin (2015-2020)10.8.4 Am Cube Wearable Physical Capacity Evaluation System Products Offered10.8.5 Am Cube Recent Development10.9 Novel DE10.9.1 Novel DE Corporation Information10.9.2 Novel DE Description, Business Overview and Total Revenue10.9.3 Novel DE Wearable Physical Capacity Evaluation System Sales, Revenue and Gross Margin (2015-2020)10.9.4 Novel DE Wearable Physical Capacity Evaluation System Products Offered10.9.5 Novel DE Recent Development10.10 GaitUp10.10.1 Company Basic Information, Manufacturing Base and Competitors10.10.2 Wearable Physical Capacity Evaluation System Product Category, Application and Specification10.10.3 GaitUp Wearable Physical Capacity Evaluation System Sales, Revenue, Price and Gross Margin (2015-2020)10.10.4 Main Business Overview10.10.5 GaitUp Recent Development10.11 Exel10.11.1 Exel Corporation Information10.11.2 Exel Description, Business Overview and Total Revenue10.11.3 Exel Wearable Physical Capacity Evaluation System Sales, Revenue and Gross Margin (2015-2020)10.11.4 Exel Wearable Physical Capacity Evaluation System Products Offered10.11.5 Exel Recent Development10.12 ReTiSense10.12.1 ReTiSense Corporation Information10.12.2 ReTiSense Description, Business Overview and Total Revenue10.12.3 ReTiSense Wearable Physical Capacity Evaluation System Sales, Revenue and Gross Margin (2015-2020)10.12.4 ReTiSense Wearable Physical Capacity Evaluation System Products Offered10.12.5 ReTiSense Recent Development10.13 Sensor Medica10.13.1 Sensor Medica Corporation Information10.13.2 Sensor Medica Description, Business Overview and Total Revenue10.13.3 Sensor Medica Wearable Physical Capacity Evaluation System Sales, Revenue and Gross Margin (2015-2020)10.13.4 Sensor Medica Wearable Physical Capacity Evaluation System Products Offered10.13.5 Sensor Medica Recent Development10.14 H/p/cosmos10.14.1 H/p/cosmos Corporation Information10.14.2 H/p/cosmos Description, Business Overview and Total Revenue10.14.3 H/p/cosmos Wearable Physical Capacity Evaluation System Sales, Revenue and Gross Margin (2015-2020)10.14.4 H/p/cosmos Wearable Physical Capacity Evaluation System Products Offered10.14.5 H/p/cosmos Recent Development10.15 MediTouch10.15.1 MediTouch Corporation Information10.15.2 MediTouch Description, Business Overview and Total Revenue10.15.3 MediTouch Wearable Physical Capacity Evaluation System Sales, Revenue and Gross Margin (2015-2020)10.15.4 MediTouch Wearable Physical Capacity Evaluation System Products Offered10.15.5 MediTouch Recent Development

11 Wearable Physical Capacity Evaluation System Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis11.1 Wearable Physical Capacity Evaluation System Key Raw Materials11.1.1 Key Raw Materials11.1.2 Key Raw Materials Price11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure11.2.1 Raw Materials11.2.2 Labor Cost11.2.3 Manufacturing Expenses11.3 Wearable Physical Capacity Evaluation System Industrial Chain Analysis11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis11.4.1 Market Opportunities and Drivers11.4.2 Market Challenges11.4.3 Market Risks11.4.4 Porters Five Forces Analysis

12 Market Strategy Analysis, Distributors12.1 Sales Channel12.2 Distributors12.3 Downstream Customers

13 Research Findings and Conclusion

14 Appendix14.1 Methodology/Research Approach14.1.1 Research Programs/Design14.1.2 Market Size Estimation14.1.3 Market Breakdown and Data Triangulation14.2 Data Source14.2.1 Secondary Sources14.2.2 Primary Sources14.3 Author Details14.4 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Continue reading here:
In-depth Analysis of How COVID-19 is Impacting the Wearable Physical Capacity Evaluation System Market | Trend, CAGR Status, Growth, Analysis and...

The coronavirus, COVID-19, which originated in China and is responsible for the global pandemic, has a unique structural feature that none of its closest viral relatives yet identified have, a furin polybasic cleavage site.

Cleavage sites similar to that found in COVID-19 are present in some naturally-occurring coronaviruses, but in completely separate evolutionary pathways from COVID-19.

It has also been demonstrated that such coronavirus cleavage sites can be modified by genetic engineering to alter viral pathogenicity, sometimes increasing it.

For example, in a 2011 study, using site-directed mutagenesis, a non-infective influenza virus was transformed into a pathogenic one by the replacement of two native amino acids in its cleavage site with two new basic amino acids.

Scientists in China have used site-directed mutagenesis to alter the cleavage site of an infectious bronchitis virus by introducing basic amino acids, thereby increasing its pathogenicity and resulting in a gain of function such that the new virus was capable of infecting the brain producing severe encephalitis.

An alternative method for introducing a polybasic cleavage site and producing a pathogenic virus from a naturally-occurring non-pathogenic one is by a technique called reassortment or mixing two or more viruses in a host animal or cell culture system from which a new virus emerges through a natural recombination process.

The scientific conventional wisdom claims that COVID-19 is a naturally-occurring bat beta-coronavirus that jumped from animals to humans presumably in the Wuhan Seafood Market, an assertion with which the Chinese Communist Party and the World Health Organisation wholeheartedly agree.

There is also general, if unproven, agreement within the scientific community that the closest relative to COVID-19, and perhaps the strain from which it evolved, is another bat beta-coronavirus named RaTG13.

But RaTG13 does not have COVID-19s furin polybasic cleavage site nor do any of the other close relatives that have been so far identified.

One of the main reasons we do not yet know the origin of COVID-19 is because China has not opened its research files and databases for inspection, sources containing information about the vast number of coronaviruses they have isolated and the experiments conducted on them.

One example is RaBtCoV/4991 (GenBank KP876546), which is one of the many bat coronaviruses isolated from an abandoned mineshaft in Yunnan Province, often mentioned as a potential starting point for a human disease outbreak.

Although isolated in 2013, RaBtCoV/4991 has never been fully sequenced or practically studied at all, even though, according to one source, the RaBtCoV/4991 short sequence is a 100 per cent match for RaTG13 and SNU01, the viral isolate from the first COVID-19 patient in South Korea.

Applying the bioengineering techniques of recombination, site-directed mutagenesis and reassortment, CoVid-19 could have been created through the introduction of a furin polybasic cleavage site onto an appropriate coronavirus backbone from the catalogue of isolated strains in Chinese laboratories.

China also has animal models to test the ability of such new viruses to infect humans.

It is only the lack of candour by the Chinese government that prevents the world from knowing the true origin of COVID-19.

(Disclaimer: The opinions expressed above are the personal views of the author and do not reflect the views of ZMCL)

Continued here:
How China could have made COVID-19 while hiding its origin - WION

The research repot of Feed Additive Nosiheptide Premix Market presents the in the depth analysis on the basis of different parameters. The research report on Global Feed Additive Nosiheptide Premix Market includes various segments. The study report presents the market overview as market size, revenue, share, forecast and market drivers. In addition, report offers an in depth analysis about the product scope and market opportunities and market risks for the participants. The report contains various subjects. Reports provides the description about the profile of the top manufacturers of the Global Feed Additive Nosiheptide Premix Market. Also the information about market price, revenue, sales analysis and market Global market share from the base year 2019 to 2025 is provided.

This study covers following key players:Mitsubishi CompanyZhejiang Esigma Animal HealthZheJiang MingZhu Animal Health ProductsChattha GroupAnhui Wanbei PharmaceuticalFenghe Bio-TechnologyZhejiang University Sunny Nutrition TechnologyBornsun BioengineeringShandong Shengli Bioengineering

Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/4578720?utm_source=Pooja

In this report, Market driving forces along with the market risks are presented. The market is segmented on the basis of application and market share & market growth rate by product type. Market breakdown data are shown on the regional and country level to present the sales and revenue of the market in the world. Competitive situation of the vendors is presented and analysed emphatically by landscape contrast. This section is important as it sheds light on the sales growth of various country level and regional level Global Feed Additive Nosiheptide Premix Market. Furthermore, study report provides an analysis for the consumers to break the sales data at the country level across the globe.

In addition, the research report on Global Feed Additive Nosiheptide Premix Market gives the in depth analysis of data source, appendix, research findings, customers, distributors, sales channel and conclusion of the market. Furthermore, reports presents come key drivers which contribute to the growth of the Global Feed Additive Nosiheptide Premix Market. In addition, report provides some key reasons which can hamper the growth of the market during the forecast period. Thus study offers the growth estimation of the market on the basis of calculation by various segmentation and past and current data. This way research report can help the consumers to take the strategic initiatives for their growth in the Feed Additive Nosiheptide Premix industry.

Access Complete Report @ https://www.orbisresearch.com/reports/index/global-feed-additive-nosiheptide-premix-market-growth-2020-2025?utm_source=Pooja

Market segment by Type, the product can be split into Below 4%Between(4%-12%)Market segment by Application, split into LivestockPoultry

Moreover, the study report presents the company profiles of players functioning in the market as well as the new entrants for the competition. Thus the competitive landscape provides the detailed information about the company with total revenue, Global presence, market potential and sales analysis of each player participating in the industry. Thus the report is beneficial for any client to expand the market growth in this industry by studying every segment covered in this research report.

Some TOC Points:

1 Industry Overview of Feed Additive Nosiheptide Premix2 Major Manufacturers Analysis of Feed Additive Nosiheptide Premix3 Global Price, Sales and Revenue Analysis of Feed Additive Nosiheptide Premix by Regions, Manufacturers, Types and ApplicationsContinued

For Enquiry before buying report @ https://www.orbisresearch.com/contacts/enquiry-before-buying/4578720?utm_source=Pooja

Some TOC Points:1 Scope of the Report2 Executive Summary3 Global Feed Additive Nosiheptide Premix by Company4 Feed Additive Nosiheptide Premix by RegionsContinued

About Us:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155

See the rest here:
Global Feed Additive Nosiheptide Premix Market anticipated grow at a CAGR of xx% over the forecast period 2020-2025 :Mitsubishi Company, Zhejiang...

Bournemouth, UK and Newark, CA, USA, 20th April 2020 /SciadNewswire/Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering companyATUM, today announced that Solentim will bundle access to the Leap-In Transposaseplatform together with the Solentim VIPS single cell cloning instrument. Leap-In Transposases enable stable high titer clones to be isolated whilst screening orders of magnitude fewer clones than alternative strategies. The VIPS seeding and clonality validation system is optimized to efficiently isolate and track each high expressing clone. This new commercial agreement will enable Solentims customers all over the world to readily access the Leap-In Transposase technology.

This agreement further cements our partnership with ATUM, explained Dr Ian Taylor, Chief Business Officer of Solentim. Over the past few months, we have seen pharma customers receive the first IND approvals using Leap-In Transposase, giving confidence to other customers that Leap-In combined with the VIPS technology is a sound choice when implementing their commercial CLD workflow.

We have fully embraced the VIPS technology from Solentim within our own company and it has become a cornerstone of our cell line development process. Solentim has been an outstanding partner to work with and we look forward to expanding our commercial success for Leap-In using their strong brand in CLD and global routes to market commented Dr Jeremy Minshull, CEO of ATUM.

About VIPSVIPS from Solentim is a unique All-in-One instrument which performs single cell seeding into 96 well plates, verifying success by z-stack imaging of the nanolitre (nL) volume droplets, and then performing whole well imaging of the single cell for the regulatory requirements for clonally-derived MCB.

About Leap-In Transposase TechnologyThe Leap-In Transposaserapidly catalyses the stable integration of genes into a target genome. Genes are integrated as multiple independent copies with structural integrity perfectly maintained. This greatly reduces the screening burden required compared with slower, more traditional "random integration" methods where the introduced DNA is randomly fragmented and often rearranged. ATUM's Leap-In technology is protected by over a dozen pending and issued patents.

About SolentimSolentim is the global leader in enabling accelerated cell line development for new biologic drugs through its proprietary intelligent automation. Solentims portfolio of products (VIPS, Cell Metricand Cell MetricCLD) enables customers to establish a simple to use and completely integrated workflow, revolutionising single cell cloning and providing documented daily whole well image assurance of monoclonality for FDA and other regulatory bodies. Solentim works with most of the worlds top 10 pharmaceutical companies and has a customer installed base of several hundred instruments. In 2018, Solentim was the recipient of two highly prestigious Queens Awards and named in the Deloitte UK Technology Fast 50. Visitwww.solentim.comfor more information.

About ATUMATUM offers an integrated pipeline of tools including gene design, optimization and synthesis, expression vectors, and platforms for protein and strain engineering and production. ATUM exploits the dependence of biological activity on well-designed sequences. ATUMs tools and solutions are fuelling the transformation of biology from a discovery science to an engineering discipline. By collaborating with our clients, ATUM accelerates breakthroughs and moves research further faster.

Corporate Contacts:

Solentim LtdIan Taylor, CBOT: +44 (0)1202 051813E:ian.taylor@solentim.com

ATUMClaes Gustafsson, CCOT: 1 (650) 853 8347E:cgustafsson@atum.bio

PR Contact:Juliette Craggs/Richard AndersonSciad Communications LtdT: +44 (0)20 3405 7892E:solentim@sciad.com

See the rest here:
Solentim and ATUM to bundle Leap-In Transposase with the VIPS single cell cloning instrument for cell line development - PharmiWeb.com

The Report Titled on Algal DHA and ARA Market analyses the adoption of Algal DHA and ARA: Product Scope, Market Overview, Market Opportunities, Market Driving Force and Market Risks. This Algal DHA and ARA Market profile the top manufacturers like (Koninklijke DSM N.V., Cabio Bioengineering (Wuhan) Co., Ltd., Corbion N.V., Lonza Group, Algisys, LLC, and Cargill, Incorporated among others.) which as long as information such as Capacity, Production, Price, Revenue, Cost, Gross, Gross Margin, Growth Rate, Import, Export, Market Share and Technological Developments. For the (historical data status 2014-2019 and 6 year forecast period 2020 to 2026), it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the Algal DHA and ARA industry. It also provide the Algal DHA and ARA market Sales Channel, Distributors, Customers, Research Findings and Conclusion, Appendix and Data Source.

Get Sample PDF (including full TOC, Tables and Figures)of Algal DHA and ARAhttps://www.coherentmarketinsights.com/insight/request-sample/2346

Algal DHA and ARA Market Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Geographically, the report includes the research on production, consumption, revenue, Algal DHA and ARA market share and growth rate, and forecast (2020-2026) of the following regions:

Do You Have Any Query Or Specific Requirement? Ask to Our IndustryExpert@https://www.coherentmarketinsights.com/insight/talk-to-analyst/2346

Important Algal DHA and ARA Market Data Available In This Report:

Published ByCoherent Market Insights Contact Us

Follow this link:
Algal DHA and ARA Market Actionable Insights Into The Consistent Growth Patterns Exhibited By The Industry - Surfacing Magazine

For decades, Cornells Adult University (CAU) has hosted Cornell alumni, their families and friends on the Ithaca campus for faculty-led programs for adults and youth during the summer months. COVID-19 made these weeklong education vacations impossible this year.

But CAU is still carrying out its mission of lifelong learning by presenting free online courses, lectures and seminars for adults and youth July 631.

Public interest in CAUs virtual summer offerings has exceeded our expectations, said Lora Gruber-Hine, director of CAU, which is part of Cornells School of Continuing Education and Summer Sessions.

The response from alumni has been overwhelmingly positive; returning students are signing up in droves, anxious to learn from their favorite faculty member and reunite with acquaintances from years past, Gruber-Hine said. Parents and first-timers are excited to engage with our instructors and find out firsthand what CAU is all about.

The online offerings were made possible by an outpouring of support from Cornell faculty and students who dedicated time, energy and expertise to make the virtual program a reality, Gruber-Hine said.

The high demand for CAUs ambitious, first-ever Virtual Summer Program has resulted in full enrollment for weeklong, faculty-led courses for adults. Topics include Getting Back to Ithaca: Homers Odyssey, taught by Michael Fontaine, professor of classics; Handling the Coronavirus, at Home and Abroad, taught by David Silbey, director of Cornell in Washington; and Medical Ethnobotany, taught by plant biologist Guilia Friso, senior research associate in the School of Integrative Plant Science.

But daily live webinars are open for registration. Topics include:

For youth and teens ages 9 to 15, CAUs free virtual activities include daily online classes on topics such as veterinary science, bioengineering, Supreme Court decisions and creative writing. Webinars and social media meetups will feature virtual campus tours, Q&A sessions with Cornell students, contests, trivia and more.

See the full schedule of offerings here. All online courses and webinars are free; registration is required.

Shelley Preston is the School of Continuing Education and Summer Sessions communications and marketing specialist.

Read the original here:
Adult University goes virtual with free 'education vacations' | Cornell Chronicle - Cornell Chronicle

Innovative Report on Perfusion Bioreactor Market with Competitive Analysis, New Business Developments, and Top Companies

A perfect mix of quantitative & qualitative Perfusion Bioreactor Market Market information highlighting developments, industry challenges that competitors are facing along with gaps and opportunities available and would trend in Perfusion Bioreactor Market. The study bridges the historical data from 2014 to 2019 and estimated until 2026.

Prominent players profiled in the study: Sartorius AG, Infors HT, Pall, Thermo Fisher, 3D Biotek, GE Healthcare Life Sciences, Bioengineering AG, ZETA, Eppendorf AG, Applikon Biotechnology, PBS Biotech, Inc., Cell Culture Company, Zellwerk GmbH

Sample Report with Latest Industry Trends @https://www.acquiremarketresearch.com/sample-request/377887/

Covid-19 pandemic affects most industries in the globe. Here at acquire market research we offer you comprehensive data of related industry which will help and support your business in all possible ways.

This Report Provides an overview of the Perfusion Bioreactor market, containing global revenue, global production, sales, and CAGR. Also describe Perfusion Bioreactor product scope, market overview, market opportunities, market driving force, and market risks. The forecast and analysis of the Perfusion Bioreactor market by type, application, and region are also presented. The next part of the report provides a full-scale analysis of Perfusion Bioreactor competitive situation, sales, revenue and global market share of major players in the Perfusion Bioreactor industry. The basic information, as well as the profiles, applications, and specifications of products market performance along with Business Overview, are offered.

Small Scale (100 Liters), Mid-Scale (100 Liters to 1,000 Liters), Large Scale (>1,000 Liters): Small Scale (100 Liters), Mid-Scale (100 Liters to 1,000 Liters), Large Scale (>1,000 Liters)

Application: Biopharmaceutical, Biotechnology, Others

Geographical Regions: North America, Europe, Central & South America, Asia-Pacific, and the Middle East & Africa, etc.

Get Reasonable Discount on this Premium Report @https://www.acquiremarketresearch.com/discount-request/377887/

Scope of the Perfusion Bioreactor Report:

Worldwide Perfusion Bioreactor Market 2020, Market Size Value CAGR (XX %) and revenue (USD Million) for the historical years (2016 to 2019) and forecast years (2020 to 2026), with SWOT analysis, Industry Analysis, Demand, Sales, Market Drivers, Restraints, Opportunities and Forecast to 2026 cover in this research report.

As a part of our Corporate Social Responsibility, we would like to announce that we would be contributing 15 % of our profits to USA, UK, Italy, Spain and India relief fund.

This report covers the current scenario and growth prospects of the Perfusion Bioreactor Market for the period 2020-2026. The study is a professional and in-depth study with around tables and figures which provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the domain.

Finally, all aspects of the Global Perfusion Bioreactor Market are quantitatively as well qualitatively assessed to study the Global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and future prospects.

Browse Full [emailprotected] https://www.acquiremarketresearch.com/industry-reports/perfusion-bioreactor-market/377887/

About us:

Acquire Market Research is a market research-based company empowering companies with data-driven insights. We provide Market Research Reports with accurate and well-informed data, Real-Time with Real Application. A good research methodology proves to be powerful and simplified information that applied right from day-to-day lives to complex decisions helps us navigate through with vision, purpose and well-armed strategies. At Acquire Market Research, we constantly strive for innovation in the techniques and the quality of analysis that goes into our reports.

Contact Us:

Sally Mach555 Madison Avenue,5th Floor, Manhattan,New York, 10022 USAPhone No.: +1 (800) 663-5579Email ID: [emailprotected]

Read more here:
Impact of COVID-19 on Perfusion Bioreactor Market Overview with Detailed Analysis, Competitive Landscape & Forecast To 2026 - Owned